For research use only. Not for therapeutic Use.
Olokizumab (CDP 6038) is a humanized monoclonal antibody targeting the interleukin-6 (IL-6). Olokizumab can be used in research of rheumatoid arthritis (RA)[1].
| Catalog Number | I043186 |
| CAS Number | 1007223-17-7 |
| Purity | ≥95% |
| Reference | [1]. Kretsos K, et, al. Model-Based Optimal Design and Execution of the First-Inpatient Trial of the Anti-IL-6, Olokizumab. CPT Pharmacometrics Syst Pharmacol. 2014 Jun 18;3(6):e119. |
